[阿根廷遗传性血管治疗的最新情况]
Blas Larrauri1,2, Alejandro Malbrán2, Eloisa Malbrán2
1Unidad de Alergia, Asma e Inmunología Clínica, San Juan, Argentina.
Medicina
|April 8, 2025
概括
遗传性血管 (HAE) 是一种罕见的遗传性疾病,导致胀,现在可以更好地用针对布拉迪基宁的新药治疗. 本更新回顾了最新的HAE药理学和疾病形式,以改善患者护理.
科学领域:
- 遗传学和免疫学 遗传学和免疫学
- 药理学 药理学是指药理学的学科.
- 罕见疾病 罕见疾病
背景情况:
- 遗传性血管 (HAE) 是一种罕见的自体主导性疾病.
- 具有影响皮肤,胃肠道和喉的反复发作发作的特征.
- 从历史上看,由于C1抑制剂缺乏而导致的窒息死亡率显著.
研究的目的:
- 在阿根廷更新用于HAE治疗的新药药理.
- 简要介绍 HAE 的最新诊断和治疗进展.
- 描述新出现的遗传性血管的形式.
主要方法:
- 对HAE.目前的药理治疗方法的审查.
- 分析最近的诊断和治疗指南.
- 新发现的HAE疾病表现的描述.
主要成果:
- 鉴定布拉迪基宁作为关键调解剂,刺激了新药的开发.
- 新的治疗药物为HAE患者提供了改进的管理选择.
- 最近的进展扩大了对HAE呈现和治疗的理解.
结论:
- 对HAE治疗的药理景观已经发生了显著的变化.
- 更新的治疗策略对于有效管理HAE至关重要.
- 持续的研究对于解决HAE的复杂性至关重要.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
82
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
82
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
97
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
97
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
89
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
89
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
151
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
151